Search

76% of Spanish biotech companies says pandemic have accelerated the innovation in its market Access to Talent is one of the drivers that could increase R&D budgets for biotechnology companies in the

The Covid-19 pandemic seems to have opened up a new door to find a treatment for the virus that causes AIDS. We spoke with the CSIC and Jiménez Díaz Foundation on the future of this research

The company, headquartered in Boston (United States), centralises the drug discovery activity in its Lab at the Barcelona Science Park.

Five spin-offs and six start-ups comprise the first generation of companies accelerated at the BCN Health Booster, an initiative promoted by the University of Barcelona (UB), Barcelona Science Park

The company conducted an analysis of the productivity losses associated to premature mortality from colorectal cancer in Spain between 2008 and 2017

Small biotech companies and startups, technology and R&D centers as well as companies demand support in order to ensure the project maturity degree required by the industry, given that their

The biotechnology company Oxolife S.L. (Spain), the Energy Balance, Puberty and Reproductive Health research group of the University of Cordoba (UCO, Spain) and the Human Growth and Reproductive

AlphaFold 2, a new Artificial Intelligence platform, is being hailed as the most important advance thus far and our members have started working with it. We spoke with some of them

BetaScreen's technology is based on an algorithm capable of interpreting image biomarkers from Magnetic Resonance and CT scans, which allows to identify the presence of abnormal levels of Alzheimer's

Farmaprojects , a company specialising in the supply of generic pharmaceutical specialities, has opened a GMP-Certified Laboratory in the Barcelona Science Park for the importation and release of

Along with Elena, Maite Agüeros Bazo was awarded as Businesswoman of Navarre 2021 and Susana Sánchez as Entrepreneur of Navarre 2021.

Primary objectives: to assess the effect of vafidemstat to address negative and cognitive symptoms in schizophrenia Phase IIb adaptive trial planning to enroll 100 patients Second Phase IIb study of

Rocío Arroyo, CEO of Amadix and coordinator of the AseBio Personalised Medicine Workgroup, highlighted the role biotechnology companies play throughout the R&D cycle

Iadademstat consistently stronger in viability reduction in AML & SCLC cells Superior target engagement at low concentration in AML & SCLC cells Superior disruption of the Snag-domain protein-protein

This Thursday is the next-to-last day of COP26 and the association believes it is important to remember that biotechnology can cut greenhouse-gas emissions up to 65% and has a direct impact on 11 of